AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 179 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $3,552,000 | -26.6% | 120,230 | +18.1% | 3.86% | -23.3% |
Q1 2019 | $4,837,000 | +20.2% | 101,811 | -8.7% | 5.02% | +6.3% |
Q4 2018 | $4,024,000 | -26.4% | 111,501 | +25.6% | 4.73% | +8.7% |
Q3 2018 | $5,465,000 | +17.8% | 88,797 | +29.3% | 4.35% | +18.5% |
Q2 2018 | $4,638,000 | +247.4% | 68,666 | +179.2% | 3.67% | +264.9% |
Q1 2018 | $1,335,000 | -77.3% | 24,597 | -75.0% | 1.01% | -74.2% |
Q4 2017 | $5,877,000 | – | 98,350 | – | 3.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,464,749 | $98,944,000 | 34.86% |
Foresite Capital Management III, LLC | 1,708,046 | $115,379,000 | 24.85% |
Eversept Partners, LP | 226,902 | $15,327,230 | 7.01% |
SECTORAL ASSET MANAGEMENT INC | 615,870 | $41,602,000 | 4.65% |
DAFNA Capital Management LLC | 131,770 | $8,901,000 | 4.17% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 68,666 | $4,638,000 | 3.67% |
Asymmetry Capital Management, L.P. | 49,756 | $3,361,000 | 3.30% |
PFM Health Sciences, LP | 2,720,218 | $183,751,000 | 2.88% |
HealthCor Management, L.P. | 1,314,290 | $88,780,000 | 2.82% |
Boulegeris Investments, Inc. | 66,540 | $4,495,000 | 2.25% |